The fight against COVID19
23.82k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +1.09% | - | - | - |
| ^GSPC | -0.21% | +5.47% | +27.37% | +5595.81% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 154.28 | +1.61 | +1.05% | 4:00 pm GMT-4 | 6.92M | 7.47M | 371.30B |
| ABBV | AbbVie Inc. | 164.35 | +0.56 | +0.34% | 4:00 pm GMT-4 | 4.29M | 5.62M | 290.22B |
| PFE | Pfizer Inc. | 28.92 | +0.10 | +0.35% | 4:01 pm GMT-4 | 34.30M | 42.74M | 163.88B |
| SNY | Sanofi | 48.82 | -0.19 | -0.39% | 4:00 pm GMT-4 | 1.96M | 2.01M | 122.39B |
| REGN | Regeneron Pharmaceuticals, Inc. | 967.98 | -10.23 | -1.05% | 4:00 pm GMT-4 | 386.50k | 456.51k | 106.66B |
| GSK | GSK plc | 44.88 | -0.44 | -0.98% | 4:00 pm GMT-4 | 3.51M | 3.17M | 94.54B |
| GILD | Gilead Sciences, Inc. | 67.86 | +0.85 | +1.27% | 4:00 pm GMT-4 | 4.75M | 7.02M | 84.54B |
| MRNA | Moderna, Inc. | 132.68 | +3.62 | +2.80% | 4:00 pm GMT-4 | 2.93M | 3.84M | 50.85B |
| TAK | Takeda Pharmaceutical Company Limited | 13.31 | -0.08 | -0.60% | 4:00 pm GMT-4 | 1.19M | 1.66M | 42.07B |
| BNTX | BioNTech SE | 92.98 | +0.78 | +0.85% | 4:00 pm GMT-4 | 389.05k | 593.01k | 22.41B |
| NVAX | Novavax, Inc. | 14.4 | +1.50 | +11.63% | 4:00 pm GMT-4 | 24.79M | 12.76M | 2.12B |
| VIR | Vir Biotechnology, Inc. | 9.93 | -0.09 | -0.90% | 4:00 pm GMT-4 | 395.76k | 993.94k | 1.35B |
| INO | Inovio Pharmaceuticals, Inc. | 12.79 | -0.28 | -2.14% | 4:00 pm GMT-4 | 365.01k | 444.19k | 331.40M |
- Investing.com
Asia FX weakens as dollar recovers amid waning rate cut cheer
Investing.com-- Most Asian currencies retreated on Friday as the dollar recovered a measure of recent losses after a string of Federal Reserve officials warned that bets on interest rate cuts may be premature.
The Real DealAbbVie CEO latest heavy hitter to buy in Boca Raton
AbbVie's Richard Gonzalez with 650 Tern Point Circle in Boca Raton (Daniel Petroni, AbbVie)AbbVie CEO Richard Gonzalez is the latest heavy hitter to buy in Boca Raton. The pharma boss dropped $14.3 million on a waterfront mansion, following a string of eight-figure deals in the city. Records show Gonzalez bought the house at 650 Tern Point Circle in Boca Raton’s […]The post AbbVie CEO latest heavy hitter to buy in Boca Raton appeared first on The Real Deal.
BenzingaJohnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Thursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with the potential for an additional milestone payment. Proteologix’s portfolio includes: PX128, a bispecific antibody targeting IL-13 plus TSLP, which is ready to enter phase 1 development for moderate to severe atopic dermatitis (AD) and moderate to severe asthma. PX130, a bispecific antibody t
